Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions
Marc Tänzer, Benjamin Balluff, Jürgen Distler et al. · 2010
Read Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions by Marc Tänzer, Benjamin Balluff, Jürgen Distler et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009061.txt.
Description
Marc Tänzer and co-authors tested a blood test for early bowel growths, in PLOS ONE in 2010. Screening cuts deaths from colorectal cancer, yet many people skip current tests. Colonoscopy is effective but unpopular; stool tests are often missed. A simple blood draw could win wider acceptance.
The team measured two methylated DNA markers, SEPT9 and ALX4, in blood plasma. They judged how well the pair flagged precancerous lesions, not just cancers. Catching growths before they turn malignant is screening's real prize. Their performance figures show what such a test can and cannot yet do.
Catalog record
| CREATOR | Marc Tänzer, Benjamin Balluff, Jürgen Distler et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009061